ARATANA THERAPEUTICS, INC. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017	FY2016 12 months to Dec 31, 2016	FY2015 12 months to Dec 31, 2015	FY2014 12 months to Dec 31, 2014
Revenues
Licensing and collaboration revenue
Licensing and Collaboration
Product Sales
Total revenues
Costs and expenses
Cost of product sales
Royalty expense
Research and development
Selling, general and administrative
Amortization of intangible assets
Impairment of acquired intangible assets
Impairment of intangible assets
In-process research and development
Total costs and expenses

Loss from operations
Other income (expense)
Interest income
Interest expense
Other income (expense), net
Total other expense
Loss before income taxes
Income tax benefit
Net loss
Net loss and comprehensive loss attributable to common stockholders
Net loss per share, basic and diluted
Weighted average shares outstanding, basic and diluted

Comments